Biolinq Shine

Every glucose monitor on the market works by firing a thin filament a few millimeters under the skin with a spring-loaded applicator — the Dexcom and Abbott Libre patches that diabetics learn to click into their arm. In September 2025 the FDA cleared a sensor that does away with that step. Biolinq's Shine sits on the forearm and reads glucose through an array of microsensors that sit up to twenty times shallower than a conventional filament, with no introducer needle at all.

It is needle-free precisely because it is many-tiny-needles — a shallow microneedle array, not an optical sensor that never touches tissue.

The marketing calls it needle-free, and the curious part is that it earns the phrase by being many-tiny-needles: a grid of microneedles short enough to stay in the skin's top layers. The trick that makes them mass-producible is borrowed from chip-making — the array is etched with the same silicon fabrication used for semiconductors, which is what lets a sensor go that shallow and still ship at scale. It is not the holy grail the field has chased for a decade, a sensor that reads glucose optically without ever touching tissue; it still measures the same interstitial fluid every CGM does. The win is depth, comfort, and no applicator.

The regulatory detail is the real tell: the FDA had to create a brand-new device category for it, because no prior cleared device looked like this. That is rarer than an approval — it means a dozen needle-free aspirants, Apple's long-rumored optical sensor among them, are still on the outside. Biolinq got through by taking the pragmatic intradermal path rather than the non-invasive one.

What ships first is narrow: the cleared use is adults with type 2 diabetes who don't take insulin — a large group that filament CGMs have historically underserved, not the everyone-tracks-their-glucose longevity gadget the device is sometimes pitched as. A patch you don't have to fire into your arm, with a light that just turns blue when you're in range, is the version of glucose tracking a casual user might actually keep wearing.